GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunityBio Inc (STU:26CA) » Definitions » Long-Term Debt

ImmunityBio (STU:26CA) Long-Term Debt : €632.12 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is ImmunityBio Long-Term Debt?

ImmunityBio's Long-Term Debt for the quarter that ended in Mar. 2024 was €632.12 Mil.

ImmunityBio's quarterly Long-Term Debt declined from Sep. 2023 (€631.15 Mil) to Dec. 2023 (€624.97 Mil) but then increased from Dec. 2023 (€624.97 Mil) to Mar. 2024 (€632.12 Mil).

ImmunityBio's annual Long-Term Debt declined from Dec. 2021 (€271.12 Mil) to Dec. 2022 (€227.76 Mil) but then increased from Dec. 2022 (€227.76 Mil) to Dec. 2023 (€624.97 Mil).


ImmunityBio Long-Term Debt Historical Data

The historical data trend for ImmunityBio's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunityBio Long-Term Debt Chart

ImmunityBio Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
- 209.08 271.12 227.76 624.97

ImmunityBio Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 229.43 230.84 631.15 624.97 632.12

ImmunityBio  (STU:26CA) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


ImmunityBio Long-Term Debt Related Terms

Thank you for viewing the detailed overview of ImmunityBio's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


ImmunityBio (STU:26CA) Business Description

Traded in Other Exchanges
Address
3530 John Hopkins Court, San Diego, CA, USA, 92121
ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. Geographically, the company operates in United States and Europe. Majority of the revenue is generated from Europe.

ImmunityBio (STU:26CA) Headlines

No Headlines